{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T17:05:21Z","timestamp":1763831121492},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,13]]},"DOI":"10.7759\/cureus.8603","type":"journal-article","created":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T15:26:56Z","timestamp":1592062016000},"source":"Crossref","is-referenced-by-count":5,"title":["Cannabis-Induced Catatonia: A Case Series"],"prefix":"10.7759","author":[{"given":"Hema","family":"Mekala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zamaar","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Lone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaushal","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Ishaq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Clinical manifestations, diagnosis, and empirical treatments for catatonia","volume":"4","author":"Bhati MT","year":"2007","unstructured":"Bhati MT, Datto CJ, O\u2019Reardon JP. Clinical manifestations, diagnosis, and empirical treatments for catatonia. Psychiatry. 2007, 4:46-52.","journal-title":"Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5455\/bcp.20151217105437","article-title":"Clinical course and management of drug-induced catatonia and paranoid behavior in an adolescent","volume":"26","author":"Prajapati PR","year":"2015","unstructured":"Prajapati PR, Fabius D, Pradhan B. Clinical course and management of drug-induced catatonia and paranoid behavior in an adolescent. Klinik Psikofarmakol B\u00fclteni. 2015, 26:310-315. 10.5455\/bcp.20151217105437","journal-title":"Klinik Psikofarmakol B\u00fclteni"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2009.141","article-title":"The catatonia syndrome: forgotten but not gone","volume":"66","author":"Fink M","year":"2009","unstructured":"Fink M, Taylor MA. The catatonia syndrome: forgotten but not gone. Arch Gen Psychiatry. 2009, 66:1173-1177. 10.1001\/archgenpsychiatry.2009.141","journal-title":"Arch Gen Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2014.00054","article-title":"Gone to pot - a review of the association between cannabis and psychosis","volume":"5","author":"Radhakrishnan R","year":"2014","unstructured":"Radhakrishnan R, Wilkinson ST, D'Souza DC. Gone to pot - a review of the association between cannabis and psychosis. Front Psychiatry. 2014, 5:10.3389\/fpsyt.2014.00054","journal-title":"Front Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2015.1858","article-title":"Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013","volume":"72","author":"Hasin DS","year":"2015","unstructured":"Hasin DS, Saha TD, Kerridge BT, et al.. Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013. JAMA Psychiatry. 2015, 72:1235-1242. 10.1001\/jamapsychiatry.2015.1858","journal-title":"JAMA Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2016.01.004","article-title":"Changes in cannabis potency over the last 2 decades (1995-2014) - analysis of current data in the United States","volume":"79","author":"ElSohly MA","year":"2016","unstructured":"ElSohly MA, Mehmedic Z, Foster S, Gon C, Chandra S, Church JC. Changes in cannabis potency over the last 2 decades (1995-2014) - analysis of current data in the United States. Biol Psychiatry. 2016, 79:613\u2010619. 10.1016\/j.biopsych.2016.01.004","journal-title":"Biol Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.17226\/24625","article-title":"The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research","author":"National Academies of Sciences","year":"2017","unstructured":"National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. The National Academies Press, Washington DC; 2017. 10.17226\/24625"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1017\/s1092852900013365","article-title":"The universal field hypothesis of catatonia and neuroleptic malignant syndrome","volume":"5","author":"Carroll BT","year":"2000","unstructured":"Carroll BT. The universal field hypothesis of catatonia and neuroleptic malignant syndrome. CNS Spectr. 2000, 5:26\u201033. 10.1017\/s1092852900013365","journal-title":"CNS Spectr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1979.tb08691.x","article-title":"The oral activity of delta'-tetrahydrocannabinol and its dependence on prostaglandin e2","volume":"67","author":"Fairbairn JW","year":"1979","unstructured":"Fairbairn JW, Pickens JT. The oral activity of delta'-tetrahydrocannabinol and its dependence on prostaglandin e2. Br J Pharmacol. 1979, 67:379\u2010385. 10.1111\/j.1476-5381.1979.tb08691.x","journal-title":"Br J Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.17m02265","article-title":"Rates of synthetic cannabinoid use in adolescents admitted to a treatment facility","volume":"20","author":"Martz G","year":"2018","unstructured":"Martz G, Tankersley W, Mekala HM, Motiwala H. Rates of synthetic cannabinoid use in adolescents admitted to a treatment facility. Prim Care Companion CNS Disord. 2018, 20:17m02265. 10.4088\/PCC.17m02265","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref11","article-title":"Synthetic marijuana use and development of catatonia in a 17-year-old male","volume":"97","author":"Smith DL","year":"2014","unstructured":"Smith DL, Roberts C. Synthetic marijuana use and development of catatonia in a 17-year-old male. Minn Med. 2014, 97:38.","journal-title":"Minn Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2014.00181","article-title":"A clinical review of the treatment of catatonia","volume":"5","author":"Sienaert P","year":"2014","unstructured":"Sienaert P, Dhossche DM, Vancampfort D, De Hert M and Gazdag G. A clinical review of the treatment of catatonia. Front Psychiatry. 2014, 5:181. 10.3389\/fpsyt.2014.00181","journal-title":"Front Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5498\/wjp.v5.i2.182","article-title":"Electroconvulsive therapy in catatonic patients: efficacy and predictors of response","volume":"5","author":"Luchini F","year":"2015","unstructured":"Luchini F, Medda P, Mariani MG, Mauri M, Toni C, Perugi G. Electroconvulsive therapy in catatonic patients: efficacy and predictors of response. World J Psychiatr. 2015, 5:182\u2010192. 10.5498\/wjp.v5.i2.182","journal-title":"World J Psychiatr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/34259-cannabis-induced-catatonia-a-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:23:21Z","timestamp":1707506601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/34259-cannabis-induced-catatonia-a-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,13]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.8603","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,13]]}}}